Random Forests to Predict Rectal Toxicity Following Prostate Cancer Radiation Therapy

被引:44
|
作者
Ospina, Juan D. [1 ,2 ,3 ]
Zhu, Jian [1 ,4 ,5 ,11 ]
Chira, Ciprian [6 ]
Bossi, Alberto [7 ]
Delobel, Jean B. [6 ]
Beckendorf, Veronique [8 ]
Dubray, Bernard [3 ,9 ]
Lagrange, Jean-Leon [10 ]
Correa, Juan C. [3 ]
Simon, Antoine [1 ,2 ,11 ]
Acosta, Oscar [1 ,2 ]
de Crevoisier, Renaud [1 ,2 ,6 ,11 ]
机构
[1] Univ Rennes 1, LTSI, Rennes, France
[2] INSERM, U1099, Rennes, France
[3] Univ Nacl Colombia Sede Medellin, Escuela Estadist, Medellin, Colombia
[4] Southeast Univ, Lab Image Sci & Technol, Nanjing, Jiangsu, Peoples R China
[5] Shandong Canc Hosp & Inst, Dept Radiat Phys, Jinan, Peoples R China
[6] Ctr Eugene Marquis, Dept Radiotherapie, Rennes, France
[7] Inst Gustave Roussy, Dept Radiotherapie, Villejuif, France
[8] Ctr Alexis Vautrin, Dept Radiotherapie, Nancy, France
[9] CRLCC Henri Becquerel, Dept Radiotherapie, Rouen, France
[10] Hop Henri Mondor, Dept Radiotherapie, F-94010 Creteil, France
[11] Ctr Rech Informat Biomed Sino Francais, Rennes, France
基金
中国国家自然科学基金;
关键词
NORMAL TISSUE; COMPLICATION PROBABILITY; RADIOTHERAPY; TOLERANCE;
D O I
10.1016/j.ijrobp.2014.04.027
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To propose a random forest normal tissue complication probability (RF-NTCP) model to predict late rectal toxicity following prostate cancer radiation therapy, and to compare its performance to that of classic NTCP models. Methods and Materials: Clinical data and dose-volume histograms (DVH) were collected from 261 patients who received 3-dimensional conformal radiation therapy for prostate cancer with at least 5 years of follow-up. The series was split 1000 times into training and validation cohorts. A RF was trained to predict the risk of 5-year overall rectal toxicity and bleeding. Parameters of the Lyman-Kutcher-Burman (LKB) model were identified and a logistic regression model was fit. The performance of all the models was assessed by computing the area under the receiving operating characteristic curve (AUC). Results: The 5-year grade >= 2 overall rectal toxicity and grade >= 1 and grade >= 2 rectal bleeding rates were 16%, 25%, and 10%, respectively. Predictive capabilities were obtained using the RF-NTCP model for all 3 toxicity endpoints, including both the training and validation cohorts. The age and use of anticoagulants were found to be predictors of rectal bleeding. The AUC for RF-NTCP ranged from 0.66 to 0.76, depending on the toxicity endpoint. The AUC values for the LKB-NTCP were statistically significantly inferior, ranging from 0.62 to 0.69. Conclusions: The RF-NTCP model may be a useful new tool in predicting late rectal toxicity, including variables other than DVH, and thus appears as a strong competitor to classic NTCP models. (C) 2014 Elsevier Inc.
引用
收藏
页码:1024 / 1031
页数:8
相关论文
共 50 条
  • [31] Proctoscopic evaluation of rectal toxicity after radiohormone therapy in prostate cancer
    Galuppi, A.
    Deodato, F.
    Shukulli, E.
    Ippolito, E.
    Digesu, C.
    Tagliaferri, L.
    Macchia, G.
    Cammelli, S.
    Valentini, V.
    Morganti, A. G.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S678 - S678
  • [32] Positive Prostate Biopsy Following Radiation Therapy Can Predict Metastasis-Free Survival In Localized Prostate Cancer
    Zapatero, A.
    Fernandez Banda, L.
    Buscher, D.
    Torres, L.
    Cruz Conde, A.
    Martin de Vidales, C. C.
    Adrados, M.
    Olivier, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E150 - E150
  • [33] Biochemical failure in prostate cancer following radiation therapy
    Makarewicz, Roman
    Reszke, Joanna
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2006, 10 (04): : 152 - 155
  • [34] Rectourethral fistulae following radiation therapy for prostate cancer
    Lane, BR
    Stein, DE
    Angermeier, KW
    Strong, S
    Fergany, A
    Remzi, F
    JOURNAL OF UROLOGY, 2004, 171 (04): : 16 - 16
  • [35] EJACULATORY DYSFUNCTION FOLLOWING RADIATION THERAPY FOR PROSTATE CANCER
    Stember, D. S.
    Deveci, S.
    Akin-Olgubade, Y.
    Mulhall, J. P.
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 176 - 176
  • [36] TESTOSTERONE LEVELS FOLLOWING RADIATION THERAPY FOR PROSTATE CANCER
    Haseltine, Justin
    Benfante, Nicole
    Zelefsky, Michael
    Mulhall, John
    JOURNAL OF UROLOGY, 2020, 203 : E1174 - E1174
  • [37] Early toxicity with stereotactic body radiation therapy for prostate cancer
    Saavedra Bejarano, J.
    Rubio Jimenez, M.
    Vicente Ruiz, P.
    Ortiz Seidel, M.
    Marquez Garcia-Salazar, M.
    Illescas Vacas, A.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1688 - S1688
  • [38] Markers of Toxicity and Response to Radiation Therapy in Patients With Prostate Cancer
    Nasser, Nicola J.
    Klein, Jonathan
    Agbarya, Abed
    ADVANCES IN RADIATION ONCOLOGY, 2021, 6 (01)
  • [39] Rectal dose variation in image guided radiation therapy of prostate cancer
    Chen, L.
    Paskalev, K.
    Xu, X.
    Zhu, J.
    Wang, L.
    Price, R.
    Horwitz, E.
    Feigenberg, S.
    Pollack, A.
    Ma, C.
    MEDICAL PHYSICS, 2006, 33 (06) : 2189 - 2189
  • [40] A Novel Methodology to Predict Late Urinary Toxicity Following Prostate Radiation Therapy-based on Bladder Wall Dosimetry
    Ahmed, A.
    Egleston, B.
    Alcantara, P.
    Pollack, A.
    Li, L.
    Horwitz, E. M.
    Buyyounouski, M. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S418 - S419